射血分数轻度降低的心力衰竭:在争议中求索  

Heart failure with mildly reduced ejection fraction:explore in the controversy

作　　者：李卓津 史云静 金玮[1] LI Zhuojin;SHI Yunjing;JIN Wei(Department of Cardiology,Ruijin Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200025,China)

机构地区：[1]上海交通大学医学院附属瑞金医院心脏内科,上海200025

出　　处：《世界临床药物》2022年第5期492-496,共5页World Clinical Drug

基　　金：国家自然科学基金项目(82070401);上海市优秀学术带头人项目(21XD1402100)。

摘　　要：2016年射血分数中间值的心力衰竭(heart failure with mid-range ejection fraction,HFmrEF)首次作为一种新的心力衰竭(heart failure,HF)分型进入学术界的视野。随着对该领域研究认识的深入,2021年欧洲心脏病学会及2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会新版HF指南将其重新定义为射血分数轻度降低的HF(heart failure with mildly reduced ejection fraction,HFmrEF)。命名的更改揭示着目前学术界对HFmrEF的认知已进入全新阶段。现对HFmrEF的流行病学、临床特征、预后转归及治疗等方面进行综述。Heart failure with mid-range ejection fraction(HFmrEF)entered the academic field for the first time as a new classification of heart failure(HF)in 2016.With the development of relevant research in this field,the 2021 European Society of Cardiology and 2022 American Heart Association/American College of Cardiology/American Heart Failure Society new HF guidelines redefined it as heart failure with mildly reduced ejection fraction(HFmrEF).The name change reveals the understanding of HFmrEF has entered a new era.This paper reviewed the epidemiology,clinical characteristics,prognosis and treatment of HFmrEF.

关 键 词：射血分数轻度降低的心力衰竭 射血分数中间值的心力衰竭 心力衰竭 

分 类 号：R541.61[医药卫生—心血管疾病]